Sivers Semiconductors Clears Debt Hurdle and Sets Earnings Calendar Ahead of Nasdaq Dual Listing

Swedish chipmaker Sivers Semiconductors restructures debt, raises capital, and sees insider buying ahead of Nasdaq dual listing; Q2 results delayed to Aug 27 for US GAAP compliance.

The path to a US listing is never purely about paperwork. For Sivers Semiconductors, it has also meant restructuring debt, raising fresh capital, and gathering a slate of insider purchases that come with a 12-month holding pledge. The Swedish chip company, which trades in Stockholm under the ticker SIVE, is laying the groundwork for a dual listing on the Nasdaq, and the next milestone arrives on August 27 — the rescheduled release of its second-quarter results, now prepared under US accounting standards.

In early July, the company closed a directed share issue worth roughly 700 million Swedish kronor, drawing demand from both domestic and international institutions that allowed it to oversubscribe the offering. That capital injection followed a key debt-reduction move: lender Bootstrap Europe converted a $12 million convertible note into about 22.8 million new ordinary shares. The conversions dilute existing equity, but they also lighten the balance sheet ahead of a listing that requires compliance with the Public Company Accounting Oversight Board’s standards and US GAAP.

Three days before a management lock-up period from the April capital raise expired on July 16, five board members — Bami Bastani, Karin Raj, Helena Svancar, Todd Thomson, and Joakim Nideborn — bought shares in the open market, with a mandatory holding period of 12 months. CEO Vickram Vathulya also added to his personal stake. The timing, just as the trading window was about to reopen, is often read by market watchers as a statement of long-term confidence. The purchases were pre-approved by the annual general meeting.

The reporting calendar has now been set for the rest of 2026 and early 2027. The Q2 report, originally due on July 9, was postponed to August 27 to allow the company to align its financial controls with PCAOB requirements. Q3 results will follow on November 26, and the Q4 report is scheduled for February 25, 2027. Vathulya has described the delay as a sign of maturity in internal reporting processes as the company scales for global capital markets.

The share price has been anything but stable through this transformation. At €3.96, the stock has recovered 4.27 percent from the previous close of €3.80, but it still sits roughly 52 percent below its level 30 days ago. On June 3, it hit a 52-week high of €10.23; just three months earlier, on March 3, it touched a low of €0.27 — a range that has produced a 1,394 percent swing from trough to current levels. The 14-day relative strength index stands at 38.4, close to oversold territory, while the annualized 30-day volatility of 154.49 percent underscores the turbulence.

The company’s market capitalisation is now about €1.25 billion, already reflecting the issuance of new shares. Technical indicators suggest the stock is under pressure — the 50-day moving average of €6.16 trades well above the current price, while the 100-day average of €3.83 hugs closer. August 27 will test whether the operational numbers can support the narrative that has driven both the insider buying and the broader strategic shift toward the US.